Curis
CRIS
#10428
Rank
C$20.72 M
Marketcap
C$0.53
Share price
-8.61%
Change (1 day)
-84.14%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2025 (TTM): C-$5.20

According to Curis's latest financial reports the company's current EPS (TTM) is C-$5.14. In 2024 the company made an earnings per share (EPS) of C-$9.84 an increase over its 2023 EPS that were of C-$12.64.

EPS history for Curis from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C-$5.20-47.14%
2024C-$9.84-22.15%
2023C-$12.64-26.17%
2022C-$17.1122.3%
2021C-$13.99-25.37%
2020C-$18.75-30.93%
2019C-$27.15-2.02%
2018C-$27.71
2016C-$62.97-10%
2015C-$69.96138.1%
2014C-$29.3840%
2013C-$20.99-25%
2012C-$27.9966.67%
2011C-$16.79

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
C$1.83-135.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$4.98-197.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
C-$0.50-90.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
C$4.38-185.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
C-$5.44 5.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
C-$15.73 206.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C$1.97-138.42%๐Ÿ‡บ๐Ÿ‡ธ USA